Dexamethasone Suppresses IL-33-exacerbated Malignant Phenotype of U87MGGlioblastoma Cells via NF-κB and MAPK Signaling Pathways

DEX inhibited the production and tumor-promoting function of IL-33. Whether DEX can benefit GBM patients remains controversial. Our results suggest that GBM patients with high IL-33 expression may benefit from DEX treatment and deserve further investigation.